clevudine
Phase 3- Indications
- Hepatitis B
Company intelligence / Profile preview
HebaBiz Biotech
Beijing, Beijing, Chinahuibaoyuan.com.cn ↗
- Ownership
- Private
- Development stage
- Phase 3
01
Overview
HebaBiz Biotech develops novel therapies targeting cancers and liver diseases using both Western biotechnology and advanced traditional Chinese medicine approaches. Its lead programs include Clevudine, a potential breakthrough anti-HBV drug now in phase III trials in China, Siroquine/JP001—a dual autophagy modulator for oncology indications with IND approval from the FDA—and Troxacitabine, a category 1.1 anticancer drug that has completed phase I studies. The company holds numerous patents, operates large GMP facilities (>68,000 m²), has over seven new drug candidates under development across multiple therapeutic areas including metabolic diseases and several cancers.
- Therapeutic areas
- OncologyMetabolic DisordersGastroenterologyInfectious Diseases
- Modalities
- Small moleculesMulti-molecular traditional Chinese medicinesChemical drugs and natural medicines
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Exclusive license from Yale University for Clevudine’s anti-HBV indication commercialization rights in China.Investment from Guangxi China-Malaysia Park Industrial Platform Investment Co., Ltd.Sponsor/collaborator relationship with Johnpro Biotech on some oncology programs.
Beyond the preview
Go deeper on HebaBiz Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on HebaBiz Biotech.